CHIEF EDITOR
Claudia C. Dobler has no potential conflicts of interest to disclose.
EDITORIAL BOARD
ERS Education Council, ERS Assembly Secretaries
Ioannis Vogiatzis has received grants from Philips Respironics.
Marcus J. Schultz has no potential conflicts of interest to disclose.
Silke Meiners has no potential conflicts of interest to disclose.
Sophia E. Schiza has no potential conflicts of interest to disclose.
Pierantonio Laveneziana has received personal fees from Novartis France and from Boehringer France.
Raquel Duarte has no potential conflicts of interest to disclose.
Torsten Gerriet Blum has no potential conflicts of interest to disclose.
Anton Vonk Noordegraaf has received speakers’ fees from Actelion, MSD, Ferrer and Bayer in the past; in addition, he served on the scientific advisory board of Morphoghen.
Stelios Loukides has no potential conflicts of interest to disclose.
Rob Primhak has no potential conflicts of interest to disclose.
Apostolos Bossios has received personal fees (advisory fees and/or lecture honorarium) from Novartis, AstraZeneca, Sanofi, GSK, and TEVA.
Ane Johannessen has no potential conflicts of interest to disclose.
Alexander Möller has received personal fees from Vertex (consultancy fees) and Vifor (lecture fees).
Section Editors
Pierantonio Laveneziana has received personal fees from Novartis France and from Boehringer France.
Alexander G. Mathioudakis has received grants from Boehringer Ingelheim,
Advisory Editors
Carol L. Armour has no potential conflicts of interest to disclose.
Jayesh Mahendra Bhatt has received lecture fees from Vertex.
Stefano Elia has no potential conflicts of interest to disclose.
Frits M.E. Franssen has received personal fees from AstraZeneca, Chiesi, GlaxoSmithKline, Novartis, Boehringer Ingelheim, and TEVA.
Georgia Hardavella has no potential conflicts of interest to disclose.
Georgios Kaltsakas has no potential conflicts of interest to disclose.
Georgia Narsavage has no potential conflicts of interest to disclose.
Delphine Natali has no potential conflicts of interest to disclose.
Athanasia Pataka has no potential conflicts of interest to disclose.
Paola Pierucci has no potential conflicts of interest to disclose.
Renata Riha has no potential conflicts of interest to disclose.
Silke Ryan has no potential conflicts of interest to disclose.
Giovanni Sotgiu has no potential conflicts of interest to disclose.
Kjeld Hansen has received personal fees from GlaxoSmithKline (speaker reimbursement, Boehringer Ingelheim (consultancy fee), and AstraZeneca (consultancy fee)
Michael E. Wilson has no potential conflicts of interest to disclose.
This page was updated on 16 November 2020